Tumor-Associated Macrophages: From Mechanisms to Therapy

Noy, Roy, Pollard, Jeffrey W.·2014·Immunity

Cited by (1,010)

Items 101–200 of 1,010

  1. Beyond immune checkpoint blockade: emerging immunological strategies
    Shawn P. Kubli, Thorsten Berger, Daniel Vilarim Araújo, Lillian L. Siu, Tak W. Mak · 2021 · Nature Reviews Drug Discovery
  2. Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy
    Yuze Wu, Ming Yi, Mengke Niu, Qi Mei, Kongming Wu · 2022 · Molecular Cancer
  3. Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells
    Oh, Min-Hee, Sun, Im-Hong, Zhao, Liang, Leone, Robert D., Sun, Im-Meng, Xu, Wei, Collins, Samuel L., Tam, Ada J., Blosser, Richard L., Patel, Chirag H. et al. · 2020 · Journal of Clinical Investigation
  4. Lenvatinib plus anti-PD-1 antibody combination treatment activates CD8+ T cells through reduction of tumor-associated macrophage and activation of the interferon pathway
    Yu Kato, Kimiyo Tabata, Takayuki Kimura, Ayako Yachie‐Kinoshita, Yoichi Ozawa, Kazuhiko Yamada, Junichi Ito, Sho Tachino, Yusaku Hori, Masahiro Matsuki et al. · 2019 · PLoS ONE
  5. Anatomy of a Discovery: M1 and M2 Macrophages
    Mills, Charles Dudley · 2015 · Frontiers in Immunology
  6. B cell-derived GABA elicits IL-10+ macrophages to limit anti-tumour immunity
    Baihao Zhang, Alexis Vogelzang, Michio Miyajima, Yuki Sugiura, Yibo Wu, Kenji Chamoto, Rei Nakano, Ryusuke Hatae, Rosemary J. Menzies, Kazuhiro Sonomura et al. · 2021 · Nature
  7. Chemokine-Induced Macrophage Polarization in Inflammatory Conditions
    Pieter Ruytinx, Paul Proost, Jo Van Damme, Sofie Struyf · 2018 · Frontiers in Immunology
  8. Interleukin-1 Beta—A Friend or Foe in Malignancies?
    Rebekka Bent, Lorna Moll, Stephan Grabbe, Matthias Bros · 2018 · International Journal of Molecular Sciences
  9. Tumor Microenvironment Dynamics in Clear-Cell Renal Cell Carcinoma
    Lynda H. Vuong, Ritesh R. Kotecha, Martin Henner Voss, A. Ari Hakimi · 2019 · Cancer Discovery
  10. Programming CAR-T cells to kill cancer
    Louai Labanieh, Robbie G. Majzner, Crystal Lee Mackall · 2018 · Nature Biomedical Engineering
  11. The P2X7 Receptor in Inflammatory Diseases: Angel or Demon?
    Savio, Luiz E. B., de Andrade Mello, Paola, da Silva, Cleide Gonçalves, Coutinho-Silva, Robson · 2018 · Frontiers in Pharmacology
  12. Tumor Immune Microenvironment and Immunosuppressive Therapy in Hepatocellular Carcinoma: A Review
    Kyoko Oura, Asahiro Morishita, Joji Tani, Tsutomu Masaki · 2021 · International Journal of Molecular Sciences
  13. Tumor-associated macrophages in breast cancer: Innocent bystander or important player?
    Si-Qi Qiu, Stijn J.H. Waaijer, Mieke C. Zwager, Elisabeth G.E. de Vries, Bert van der Vegt, Carolien P. Schröder · 2018 · Cancer Treatment Reviews
  14. Macrophages and microglia in glioblastoma: heterogeneity, plasticity, and therapy
    Fatima Khan, Lizhi Pang, Madeline Dunterman, Maciej S. Lesniak, Amy B. Heimberger, Peiwen Chen · 2023 · Journal of Clinical Investigation
  15. Paclitaxel Reduces Tumor Growth by Reprogramming Tumor-Associated Macrophages to an M1 Profile in a TLR4-Dependent Manner
    Wanderley, Carlos W., Colón, David F., Luiz, João Paulo M., Oliveira, Francisco F., Viacava, Paula R., Leite, Caio A., Pereira, Janaina A., Silva, Camila M., Silva, Cassia R., Silva, Rangel L. et al. · 2018 · Cancer Research
  16. Tumour-associated macrophages-derived CXCL8 determines immune evasion through autonomous PD-L1 expression in gastric cancer
    Chao Lin, Hongyong He, Hao Liu, Ruochen Li, Yifan Chen, Yangyang Qi, Qi Jiang, Lingli Chen, Peipei Zhang, Heng Zhang et al. · 2019 · Gut
  17. Reprogramming of Tumor-Associated Macrophages with Anticancer Therapies: Radiotherapy versus Chemo- and Immunotherapies
    Géraldine C. Genard, Stéphane Lucas, Carine Michiels · 2017 · Frontiers in Immunology
  18. Oncolytic viruses as engineering platforms for combination immunotherapy
    Kwame Twumasi‐Boateng, Jessica L. Pettigrew, Y. Y. Eunice Kwok, John Cameron Bell, Brad H. Nelson · 2018 · Nature reviews. Cancer
  19. The roles of tumor-associated macrophages in tumor angiogenesis and metastasis
    Luo‐Qin Fu, Wenlin Du, Maohua Cai, Jiayu Yao, Yuanyuan Zhao, Xiaozhou Mou · 2020 · Cellular Immunology
  20. Tumor-Produced Interleukin-8 Attracts Human Myeloid-Derived Suppressor Cells and Elicits Extrusion of Neutrophil Extracellular Traps (NETs)
    Alfaro, Carlos, Teijeira, Alvaro, Oñate, Carmen, Pérez, Guiomar, Sanmamed, Miguel F., Andueza, Maria Pilar, Alignani, Diego, Labiano, Sara, Azpilikueta, Arantza, Rodriguez-Paulete, Alfonso et al. · 2016 · Clinical Cancer Research
  21. Breast Cancer Metastasis: Mechanisms and Therapeutic Implications
    Misung Park, Do‐Hee Kim, Sunghyub Ko, Ayoung Kim, Kyumin Mo, Hyunho Yoon · 2022 · International Journal of Molecular Sciences
  22. Plasticity of myeloid-derived suppressor cells in cancer
    Tcyganov, Evgenii, Mastio, Jerome, Chen, Eric, Gabrilovich, Dmitry I · 2018 · Current Opinion in Immunology
  23. Lactic Acid and an Acidic Tumor Microenvironment suppress Anticancer Immunity
    Wang, Joy X., Choi, Stephen Y.C., Niu, Xiaojia, Kang, Ning, Xue, Hui, Killam, James, Wang, Yuzhuo · 2020 · International Journal of Molecular Sciences
  24. RNA m6A methylation orchestrates cancer growth and metastasis via macrophage reprogramming
    Huilong Yin, Xiang Zhang, Pengyuan Yang, Xiaofang Zhang, Yingran Peng, Da Li, Yanping Yu, Ye Wu, Yidi Wang, Jinbao Zhang et al. · 2021 · Nature Communications
  25. FcγRs Modulate the Anti-tumor Activity of Antibodies Targeting the PD-1/PD-L1 Axis
    Rony Dahan, Emanuela I. Sega, John Engelhardt, Mark Selby, Alan J. Korman, Jeffrey V. Ravetch · 2015 · Cancer Cell
  26. Recent advances in nanomaterial-based synergistic combination cancer immunotherapy
    Wei Sang, Zhan Zhang, Yunlu Dai, Xiaoyuan Shawn Chen · 2019 · Chemical Society Reviews
  27. Metabolic regulatory crosstalk between tumor microenvironment and tumor-associated macrophages
    Chen, Degao, Zhang, Xiaomei, Li, Zhongjun, Zhu, Bo · 2021 · Theranostics
  28. Immunosuppressive cells in tumor immune escape and metastasis
    Yang Liu, Xuetao Cao · 2015 · Journal of Molecular Medicine
  29. Fetal monocytes and the origins of tissue-resident macrophages
    Guillaume Hoeffel, Florent Ginhoux · 2018 · Cellular Immunology
  30. Immune crosstalk in cancer progression and metastatic spread: a complex conversation
    Hannah Garner, Karin E. de Visser · 2020 · Nature reviews. Immunology
  31. Aryl hydrocarbon receptor Controls Monocyte Differentiation into dendritic Cells versus Macrophages
    Goudot, Christel, Coillard, Alice, Villani, Alexandra-Chloé, Gueguen, Paul, Cros, Adeline, Sarkizova, Siranush, Tang-Huau, Tsing-Lee, Bohec, Mylène, Baulande, Sylvain, Hacohen, Nir et al. · 2017 · Immunity
  32. Contribution to Tumor Angiogenesis From Innate Immune Cells Within the Tumor Microenvironment: Implications for Immunotherapy
    Adriana Albini, Antonino Bruno, Douglas McClain Noonan, Lorenzo Mortara · 2018 · Frontiers in Immunology
  33. Tumor-Associated Macrophages in Human Breast, Colorectal, Lung, Ovarian and Prostate Cancers
    Irina Larionova, Gulnara Maratovna Tuguzbaeva, Anastasia A. Ponomaryova, Marina N. Stakheyeva, Н. В. Чердынцева, В. Н. Павлов, Е. Л. Чойнзонов, Julia G. Kzhyshkowska · 2020 · Frontiers in Oncology
  34. Alliance with EPR Effect: Combined Strategies to Improve the EPR Effect in the Tumor Microenvironment
    Jooho Park, Yongwhan Choi, Hyeyoun Chang, Wooram Um, Ju Hee Ryu, Ick Chan Kwon · 2019 · Theranostics
  35. The mucin MUC1 modulates the tumor immunological microenvironment through engagement of the lectin Siglec-9
    Richard Beatson, Virginia Tajadura‐Ortega, Daniela Achkova, Gianfranco Picco, Theodora-Dorita Tsourouktsoglou, Sandra Klausing, M. C. J. Hillier, John F. Maher, Thomas Noll, Paul R. Crocker et al. · 2016 · Nature Immunology
  36. Overcoming TGFβ-mediated immune evasion in cancer
    Tauriello, Daniele V. F., Sancho, Elena, Batlle, Eduard · 2022 · Nature Reviews Cancer
  37. Tumor-associated macrophages: potential therapeutic strategies and future prospects in cancer
    Li, Chunxiao, Xu, Xiaofei, Wei, Shuhua, Jiang, Ping, Xue, Lixiang, Wang, Junjie · 2021 · Journal for ImmunoTherapy of Cancer
  38. Hybrid cellular membrane nanovesicles amplify macrophage immune responses against cancer recurrence and metastasis
    Lang Rao, Lei Wu, Zhida Liu, Rui Tian, Guocan Yu, Zijian Zhou, Kuikun Yang, Hong‐Gang Xiong, Anli Zhang, Guang-Tao Yu et al. · 2020 · Nature Communications
  39. Tumor macrophages are pivotal constructors of tumor collagenous matrix
    Ran Afik, Ehud Zigmond, Milena Vugman, Mordehay Klepfish, Elee Shimshoni, Metsada Pasmanik‐Chor, Anjana Shenoy, Elad Bassat, Zamir Halpern, Tamar Geiger et al. · 2016 · The Journal of Experimental Medicine
  40. Lipid droplet‐dependent fatty acid metabolism controls the immune suppressive phenotype of tumor‐associated macrophages
    Hao Wu, Yijie Han, Yasmina Rodriguez Sillke, Hongzhang Deng, Sophiya Siddiqui, Christoph Treese, Franziska Schmidt, Marie Friedrich, Jacqueline Keye, Jiajia Wan et al. · 2019 · EMBO Molecular Medicine
  41. RETRACTED ARTICLE: LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis
    Yiran Liang, Xiaojin Song, Yaming Li, Bing Chen, Wenjing Zhao, Lijuan Wang, Hanwen Zhang, Ying Liu, Dianwen Han, Ning Zhang et al. · 2020 · Molecular Cancer · Retracted
  42. Targeting tumor-associated macrophages and granulocytic myeloid-derived suppressor cells augments PD-1 blockade in cholangiocarcinoma
    Emilien J. Loeuillard, Jingchun Yang, EeeLN H. Buckarma, Juan Wang, Yuanhang Liu, Caitlin B. Conboy, Kevin D. Pavelko, Ying Li, Daniel R. O’Brien, Chen Wang et al. · 2020 · Journal of Clinical Investigation
  43. CD45 Phosphatase Inhibits STAT3 Transcription Factor Activity in Myeloid Cells and Promotes Tumor-Associated Macrophage Differentiation
    Kumar, Vinit, Cheng, Pingyan, Condamine, Thomas, Mony, Sridevi, Languino, Lucia R., McCaffrey, Judith C., Hockstein, Neil, Guarino, Michael, Masters, Gregory, Penman, Emily et al. · 2016 · Immunity
  44. Tumor-Associated Macrophages (TAMs) in Colorectal Cancer (CRC): From Mechanism to Therapy and Prognosis
    Wang, Hui, Tian, Tian, Zhang, Jinhua · 2021 · International Journal of Molecular Sciences
  45. Tumor-Associated Macrophages: Implications in Cancer Immunotherapy
    Amy J. Petty, Yiping Yang · 2017 · Immunotherapy
  46. Harnessing tumor‐associated macrophages as aids for cancer immunotherapy
    Li, Xiaolei, Liu, Rui, Su, Xiao, Pan, Yongsha, Han, Xiaofeng, Shao, Changshun, Shi, Yufang · 2019 · Molecular Cancer
  47. Ang-2/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survival
    Kloepper, Jonas, Riedemann, Lars, Amoozgar, Zohreh, Seano, Giorgio, Susek, Katharina, Yu, Veronica, Dalvie, Nisha, Amelung, Robin L., Datta, Meenal, Song, Jonathan W. et al. · 2016 · Proceedings of the National Academy of Sciences
  48. Cancer-associated fibroblasts induce metalloprotease-independent cancer cell invasion of the basement membrane
    Alexandros Glentis, Philipp Oertle, Pascale Mariani, Aleksandra S. Chikina, Fatima El Marjou, Youmna Atieh, François Zaccarini, Marick E Lae, Damarys Loew, Florent Dingli et al. · 2017 · Nature Communications
  49. Tissue homeostasis and inflammation
    Meizlish, Matthew L., Franklin, Ruth A., Zhou, Xu, Medzhitov, Ruslan · 2021 · Annual Review of Immunology
  50. Ontogeny of Tissue-Resident Macrophages
    Hoeffel, Guillaume, Ginhoux, Florent · 2015 · Frontiers in Immunology
  51. <scp>IL</scp>‐1 and <scp>IL</scp>‐1 regulatory pathways in cancer progression and therapy
    Mantovani, Alberto, Barajon, Isabella, Garlanda, Cecilia · 2018 · Immunological Reviews
  52. Adaptive immune resistance at the tumour site: mechanisms and therapeutic opportunities
    Tae Kon Kim, Esten N. Vandsemb, Roy S. Herbst, Lieping Chen · 2022 · Nature Reviews Drug Discovery
  53. Macrophages: An Inflammatory Link Between Angiogenesis and Lymphangiogenesis
    Corliss, Bruce A., Azimi, Mohammad S., Munson, Jennifer M., Peirce, Shayn M., Murfee, Walter L. · 2016 · Microcirculation
  54. A Breakthrough: Macrophage-Directed Cancer Immunotherapy
    Charles Dudley Mills, Laurel L. Lenz, Robert Adam Harris · 2016 · Cancer Research
  55. Metal Drugs and the Anticancer Immune Response
    Englinger, Bernhard, Pirker, Christine, Heffeter, Petra, Terenzi, Alessio, Kowol, Christian R., Keppler, Bernhard K., Berger, Walter · 2019 · Chemical Reviews
  56. Mechanisms of Cancer Resistance to Immunotherapy
    Rilan Bai, Naifei Chen, Lingyu Li, Nawen Du, Ling Bai, Zheng Lv, Huimin Tian, Jiuwei Cui · 2020 · Frontiers in Oncology
  57. Dual roles and therapeutic targeting of tumor-associated macrophages in tumor microenvironments
    Jiasheng Xu, Lei Ding, Jianfeng Mei, Yeting Hu, Xiangxing Kong, Siqi Dai, Tongtong Bu, Qian Xiao, Kefeng Ding · 2025 · Signal Transduction and Targeted Therapy
  58. Migrastatics—Anti-metastatic and Anti-invasion Drugs: Promises and Challenges
    Aneta Gandalovičová, Daniel Rösel, Michael Fernandes, Pavel Veselý, Petr Heneberg, Vladimı́r Čermák, Lubos B. Petruzelka, Sunil Kumar, Victoria Sanz‐Moreno, Jan Brábek · 2017 · Trends in cancer
  59. Macrophage-Associated PGK1 Phosphorylation Promotes Aerobic Glycolysis and Tumorigenesis
    Yajuan Zhang, Guanzhen Yu, Huiying Chu, Xiongjun Wang, Lingling Xiong, Guoqing Cai, Ruilong Liu, Hong Gao, Bangbao Tao, Wenfeng Li et al. · 2018 · Molecular Cell
  60. CAR-T cell-mediated depletion of immunosuppressive tumor-associated macrophages promotes endogenous antitumor immunity and augments adoptive immunotherapy
    Alba Rodríguez-García, Rachel C. Lynn, Mathilde Poussin, Monika A. Eiva, Lauren C. Shaw, Roddy S. O’Connor, Nicholas G. Minutolo, Victoria Casado‐Medrano, Gonzalo López, Takami Matsuyama et al. · 2021 · Nature Communications
  61. Tumour-associated macrophages secrete pleiotrophin to promote PTPRZ1 signalling in glioblastoma stem cells for tumour growth
    Yu Shi, Yi-Fang Ping, Wenchao Zhou, Zhi Cheng He, Cong Chen, Baishijiao Bian, Lin Zhang, Lu Chen, Xun Lan, Xian Chao Zhang et al. · 2017 · Nature Communications
  62. Cell-to-cell communication: microRNAs as hormones.
    Bayraktar, Recep, Van Roosbroeck, Katrien, Calin, George A. · 2017 · Molecular Oncology
  63. A framework for the development of effective anti-metastatic agents
    Robin L. Anderson, Theo Balasas, Juliana Callaghan, R. Charles Coombes, JEFF EVANS, Jacqueline A. Hall, Sally A. Kinrade, David Jones, Paul S. Jones, Robert J. Jones et al. · 2018 · Nature Reviews Clinical Oncology
  64. Myeloid cells are required for PD-1/PD-L1 checkpoint activation and the establishment of an immunosuppressive environment in pancreatic cancer
    Yaqing Zhang, Ashley Velez-Delgado, Esha Mathew, Dongjun Li, Flor Mendez, Kevin Flannagan, Andrew D. Rhim, Diane M. Simeone, Gregory Lawrence Beatty, Marina Pasca di Magliano · 2016 · Gut
  65. The Role of Macrophages in Cancer Development and Therapy
    Cendrowicz, Ewa, Sas, Zuzanna, Bremer, Edwin, Rygiel, Tomasz P. · 2021 · Cancers
  66. Immunomodulatory activity of lenvatinib contributes to antitumor activity in the Hepa1‐6 hepatocellular carcinoma model
    Takayuki Kimura, Yu Kato, Yoichi Ozawa, Kotaro Kodama, Junichi Ito, Kenji Ichikawa, Kazuhiko Yamada, Yusaku Hori, Kimiyo Tabata, Kazuma Takase et al. · 2018 · Cancer Science
  67. Molecular-Targeted Immunotherapeutic Strategy for Melanoma via Dual-Targeting Nanoparticles Delivering Small Interfering RNA to Tumor-Associated Macrophages
    Yuan Qian, Sha Qiao, Yanfeng Dai, Guoqiang Xu, Bolei Dai, Lisen Lu, Xiang Min Yu, Qingming Luo, Zhihong Zhang · 2017 · ACS Nano
  68. Interaction of tumor-associated macrophages and cancer chemotherapy
    Larionova, Irina, Cherdyntseva, Nadezhda, Liu, Tengfei, Patysheva, Marina, Rakina, Militsa, Kzhyshkowska, Julia · 2019 · OncoImmunology
  69. Factors involved in cancer metastasis: a better understanding to “seed and soil” hypothesis
    Qiang Liu, Hongfei Zhang, Xiaoli Jiang, Caiyun Qian, Zhuoqi Liu, Daya Luo · 2017 · Molecular Cancer
  70. Arg1 expression defines immunosuppressive subsets of tumor-associated macrophages
    Sean P. Arlauckas, Seth B. Garren, Christopher Garris, Rainer H. Köhler, Juhyun Oh, Mikaël J. Pittet, Ralph Weissleder · 2018 · Theranostics
  71. Tumor-Infiltrating Immune Cells Act as a Marker for Prognosis in Colorectal Cancer
    Lele Ye, Teming Zhang, Zhengchun Kang, Gangqiang Guo, Yongji Sun, Kangming Lin, Qunjia Huang, Xinyu Shi, Zhonglin Ni, Ning Ding et al. · 2019 · Frontiers in Immunology
  72. Modulation of M2 macrophage polarization by the crosstalk between Stat6 and Trim24
    Yu, Tao, Gan, Shucheng, Zhu, Qingchen, Dai, Dongfang, Li, Ni, Wang, Hui, Chen, Xiaosong, Hou, Dan, Wang, Yan, Pan, Qiang et al. · 2019 · Nature Communications
  73. Nanoparticles and innate immunity: new perspectives on host defence
    Diana Boraschi, Paola Italiani, Roberto Palomba, Paolo Decuzzi, Albert Duschl, Bengt Fadeel, Seyed Moein Moghimi · 2017 · Seminars in Immunology
  74. Tissue-resident macrophages in omentum promote metastatic spread of ovarian cancer
    Anders Etzerodt, Morgane Moulin, Thomas Koed Doktor, Marcello Delfini, Noushin Mossadegh‐Keller, Marc Bajénoff, Michael H. Sieweke, Søren K. Moestrup, Nathalie Auphan‐Anezin, Toby Lawrence · 2020 · The Journal of Experimental Medicine
  75. Dual inhibition of Ang-2 and VEGF receptors normalizes tumor vasculature and prolongs survival in glioblastoma by altering macrophages
    Peterson, Teresa E., Kirkpatrick, Nathaniel D., Huang, Yuhui, Farrar, Christian T., Marijt, Koen A., Kloepper, Jonas, Datta, Meenal, Amoozgar, Zohreh, Seano, Giorgio, Jung, Keehoon et al. · 2016 · Proceedings of the National Academy of Sciences
  76. The Promise of Targeting Macrophages in Cancer Therapy
    J. Martin Brown, Lawrence David Recht, Samuel Strober · 2017 · Clinical Cancer Research
  77. Evaluation of FASP, SP3, and iST Protocols for Proteomic Sample Preparation in the Low Microgram Range
    Malte Sielaff, Jörg Kuharev, Toszka Bohn, Jennifer Hahlbrock, Tobias Bopp, Stefan Tenzer, Ute Distler · 2017 · Journal of Proteome Research
  78. Common risk factors for heart failure and cancer
    Wouter C. Meijers, Rudolf A. de Boer · 2019 · Cardiovascular Research
  79. Static and Dynamic DNA Loops form AP-1-Bound Activation Hubs during Macrophage Development
    Phanstiel, Douglas H., Van Bortle, Kevin, Spacek, Damek, Hess, Gaelen T., Shamim, Muhammad Saad, Machol, Ido, Love, Michael I., Aiden, Erez Lieberman, Bassik, Michael C., Snyder, Michael P. · 2017 · Molecular Cell
  80. The immune system and cancer evasion strategies: therapeutic concepts
    Muenst, S., Läubli, H., Soysal, S. D., Zippelius, A., Tzankov, A., Hoeller, S. · 2016 · Journal of Internal Medicine
  81. T cell–induced CSF1 promotes melanoma resistance to PD1 blockade
    Neubert, Natalie J., Schmittnaegel, Martina, Bordry, Natacha, Nassiri, Sina, Wald, Noémie, Martignier, Christophe, Tillé, Laure, Homicsko, Krisztian, Damsky, William, Maby-El Hajjami, Hélène et al. · 2018 · Science Translational Medicine
  82. Immunity, Hypoxia, and Metabolism–the Ménage à Trois of Cancer: Implications for Immunotherapy
    Riera-Domingo, Carla, Audigé, Annette, Granja, Sara, Cheng, Wan-Chen, Ho, Ping-Chih, Baltazar, Fátima, Stockmann, Christian, Mazzone, Massimiliano · 2020 · Physiological Reviews
  83. Molecular Profiling Reveals a Tumor-Promoting Phenotype of Monocytes and Macrophages in Human Cancer Progression
    Manesh Chittezhath, Manprit Kaur Dhillon, Jyue Yuan Lim, Damya Laoui, Irina N. Shalova, Yi Ling Teo, Jinmiao Chen, Revathy Kamaraj, Lata Nee Mani Raman, Josephine Lum et al. · 2014 · Immunity
  84. Idiopathic Pulmonary Fibrosis and Lung Cancer: Mechanisms and Molecular Targets
    Beatriz Ballester, Javier Milara, Julio Cortijo · 2019 · International Journal of Molecular Sciences
  85. Tumor microenvironment-mediated immune evasion in hepatocellular carcinoma
    Chen Chen, Zehua Wang, Yi Ding, Yanru Qin · 2023 · Frontiers in Immunology
  86. Immune infiltration in renal cell carcinoma
    Shichao Zhang, Erdong Zhang, Jinhua Long, Zuquan Hu, Jian Wei Peng, Lina Liu, Fuzhou Tang, Long Li, Yan Ouyang, Zhu Zeng · 2019 · Cancer Science
  87. Prognostic role of pretreatment blood neutrophil-to-lymphocyte ratio in advanced cancer survivors: A systematic review and meta-analysis of 66 cohort studies
    Zubing Mei, Lu Shi, Bo Wang, Jizhen Yang, Zhihong Xiao, Peixin Du, Qingming Wang, Wei Yang · 2017 · Cancer Treatment Reviews
  88. Immune Checkpoint Inhibition Overcomes ADCP-Induced Immunosuppression by Macrophages
    Shicheng Su, Jinghua Zhao, Yue Xing, Xiaoqian Zhang, Jiang Liu, Qian Ouyang, Jianing Chen, Fengxi Su, Qiang Liu, Erwei Song · 2018 · Cell
  89. Molecular mechanisms and functions of pyroptosis in inflammation and antitumor immunity
    Junwei Hou, Jung-Mao Hsu, Mien‐Chie Hung · 2021 · Molecular Cell
  90. Cancer associated fibroblasts sculpt tumour microenvironment by recruiting monocytes and inducing immunosuppressive PD-1+ TAMs
    Gok Yavuz, Betul, Gunaydin, Gurcan, Gedik, M. Emre, Kosemehmetoglu, Kemal, Karakoc, Derya, Ozgur, Figen, Guc, Dicle · 2019 · Scientific Reports
  91. Molecular Repolarisation of Tumour-Associated Macrophages
    Floris J. van Dalen, Marleen H. M. E. van Stevendaal, Felix L. Fennemann, Martijn Verdoes, Olga Ilina · 2018 · Molecules
  92. Exercise-dependent regulation of the tumour microenvironment
    Graeme J. Koelwyn, Daniela F. Quail, Xiang Zhang, Richard Mark White, Lee W. Jones · 2017 · Nature reviews. Cancer
  93. Tumour-associated macrophages drive stromal cell-dependent collagen crosslinking and stiffening to promote breast cancer aggression
    Ori Maller, Allison P. Drain, Alexander S. Barrett, Signe Borgquist, Brian Ruffell, Igor Zakharevich, Thanh Thi Mai Pham, Tina Gruosso, Hellen Kuasne, Johnathon N. Lakins et al. · 2020 · Nature Materials
  94. Yolk sac macrophage progenitors traffic to the embryo during defined stages of development
    Christopher Stremmel, R. Schuchert, F. Wagner, Raffael Thaler, Tobias Weinberger, Robert Pick, Elvira Mass, Hellen Cristina Ishikawa-Ankerhold, Andreas Margraf, S. Hutter et al. · 2018 · Nature Communications
  95. The functional crosstalk between myeloid-derived suppressor cells and regulatory T cells within the immunosuppressive tumor microenvironment
    Haist, Maximilian, Stege, Henner, Grabbe, Stephan, Bros, Matthias · 2021 · Cancers
  96. Extracellular vesicles in the tumor microenvironment: old stories, but new tales
    Liu Han, Eric W.‐F. Lam, Yu Sun · 2019 · Molecular Cancer
  97. Fibroblasts drive an immunosuppressive and growth-promoting microenvironment in breast cancer via secretion of Chitinase 3-like 1
    Noam Cohen, Ophir Shani, Yael Raz, Yoray Sharon, D Hoffman, Lilach Abramovitz, Neta Erez · 2017 · Oncogene
  98. The origin and function of tumor-associated macrophages
    Yang Liu, Xue-Tao Cao · 2014 · Cellular & Molecular Immunology
  99. The Unique Molecular and Cellular Microenvironment of Ovarian Cancer
    Thomas Worzfeld, Elke Pogge von Strandmann, M. Huber, Till Adhikary, U. Wagner, S. Reinartz, Rolf Müller · 2017 · Frontiers in Oncology
  100. Nerve Dependence: From Regeneration to Cancer
    B. Boilly, Sam Faulkner, Phillip Jobling, Hubert Hondermarck · 2017 · Cancer Cell